Pharmacists in Ripon, Wisconsin


13 Pharmacists found in Ripon
male pharmacist

Dr. Andrew T Christenson, RPH


Pharmacist
1200 W Fond Du Lac St, Ripon, WI 54971
608-712-6700     920-748-4803

female pharmacist

Bailey J Patterson, PHARMD, RPH


Pharmacist
328 Watson St, Ripon, WI 54971
920-748-5174     920-748-2066

male pharmacist

Dr. Connor Hanson, RPH


Pharmacist
328 Watson St, Ripon, WI 54971
920-748-5174    



male pharmacist

David N Duehring, RPH


Pharmacist
328 Watson St, Ripon, WI 54971
920-748-5174     920-748-2066

male pharmacist

Jason H Buttke, RPH


Pharmacist
1203 W Fond Du Lac St, Ripon, WI 54971
920-748-6005     920-361-1582

male pharmacist

Jeffrey Richard Nevens, R.PH.


Pharmacist
1200 W Fond Du Lac St, Ripon, WI 54971
920-748-1203     920-748-4803

male pharmacist

Joe Lettenberger, RPH


Pharmacist
328 Watson St, Ripon, WI 54971
920-748-5174     920-748-2066

male pharmacist

John Dalsbo


Pharmacist
W13930 Oak Haven Dr, Ripon, WI 54971
920-748-2557    

male pharmacist

Joshua M Schwartz, PHARMD


Pharmacist
1203 W Fond Du Lac St, Ripon, WI 54971
920-748-6005    

female pharmacist

Kathyrn Thomsen, RPH


Pharmacist
328 Watson St, Ripon, WI 54971
920-748-5174     920-748-2066

female pharmacist

Kelly Jo Field, PHARMD.


Pharmacist
328 Watson St, Ripon, WI 54971
920-748-5174     920-748-2066

female pharmacist

Lisa M Schmidt, PHARMD


Pharmacist
1203 W Fond Du Lac St, Ripon, WI 54971
920-748-6005     920-748-6962

male pharmacist

Zachariah Pickart, RPH


Pharmacist
1203 W Fond Du Lac St, Ripon, WI 54971
920-748-6005    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.